One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

Steven J. Insoft net worth and biography

Steven Insoft Biography and Net Worth

Insider of Omega Healthcare Investors

Steven J. Insoft (57) is our Chief Corporate Development Officer and has served in this capacity since April 1, 2015. Mr. Insoft served as President and Chief Operating Officer of Aviv REIT, Inc. since 2012, while previously serving as Chief Financial Officer and Treasurer. Prior to joining Aviv REIT, Inc. in 2005, Mr. Insoft spent eight years as a Vice President and Senior Investment Officer of Nationwide Health Properties, Inc., a publicly-traded REIT. Before that, he was President and Chief Financial Officer of CMI Senior Housing & Healthcare, Inc., a privately-held nursing home and assisted living facility operations and development company, for seven years. Mr. Insoft received an M.B.A. from Columbia University and a B.S.E. in Electrical Engineering from the University of Pennsylvania.

What is Steven J. Insoft's net worth?: The estimated net worth of Steven J. Insoft is at least $5.53 million as of June 21st, 2021. Mr. Insoft owns 184,588 shares of Omega Healthcare Investors stock worth more than $5,530,256 as of April 19th. This net worth evaluation does not reflect any other assets that Mr. Insoft may own. Learn More about Steven J. Insoft's net worth.
How do I contact Steven J. Insoft?: The corporate mailing address for Mr. Insoft and other Omega Healthcare Investors executives is 303 International Circle Suite 200, HUNT VALLEY MD, 21030. Omega Healthcare Investors can also be reached via phone at (410) 427-1700 and via email at [email protected]. Learn More on Steven J. Insoft's contact information.
Has Steven J. Insoft been buying or selling shares of Omega Healthcare Investors?: Steven J. Insoft has not been actively trading shares of Omega Healthcare Investors during the last quarter. Most recently, Steven J. Insoft sold 25,000 shares of the business's stock in a transaction on Friday, June 25th. The shares were sold at an average price of $36.71, for a transaction totalling $917,750.00. Following the completion of the sale, the insider now directly owns 184,588 shares of the company's stock, valued at $6,776,225.48. Learn More on Steven J. Insoft's trading history.
Who are Omega Healthcare Investors' active insiders?: Omega Healthcare Investors' insider roster includes Kapila Anand (Director), Neal Ballew (CAO), Daniel Booth (COO), Steven Insoft (Insider), C. Pickett (CEO), Robert Stephenson (CFO), and Burke Whitman (Director). Learn More on Omega Healthcare Investors' active insiders.

Steven J. Insoft Insider Trading History at Omega Healthcare Investors

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/25/2021	Sell	25,000	$36.71	$917,750.00	184,588
6/21/2021	Sell	25,000	$36.69	$917,250.00	184,588
1/21/2020	Sell	50,000	$44.00	$2,200,000.00	183,032
1/6/2020	Sell	50,000	$42.12	$2,106,000.00	258,032
1/31/2019	Sell	50,000	$40.00	$2,000,000.00
12/11/2018	Sell	25,000	$37.25	$931,250.00	315,720
4/11/2017	Sell	87,500	$34.00	$2,975,000.00	324,076
3/14/2017	Sell	12,500	$30.93	$386,625.00	411,576
9/12/2016	Sell	5,500	$35.91	$197,505.00	419,081

Steven J. Insoft Buying and Selling Activity at Omega Healthcare Investors

Omega Healthcare Investors Company Overview

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Today's Range

Now: $30.39

$30.00

$30.52

50 Day Range

MA: $31.03

$29.95

$32.00

2 Week Range

Now: $30.39

$26.00

$34.77

Volume

722,724 shs

Average Volume

1,747,374 shs

Market Capitalization

$7.45 billion

P/E Ratio

30.70

Dividend Yield

8.95%

Beta

0.91

Strange new buyer driving up gold

From Stansberry Research | Ad